Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Shihong Sheng"'
Autor:
Dennis McGonagle, Iain B. McInnes, Atul Deodhar, Georg Schett, May Shawi, Soumya D. Chakravarty, Alexa P. Kollmeier, Xie L. Xu, Shihong Sheng, Stephen Xu, Christopher T. Ritchlin, Proton Rahman, Phillip J. Mease
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 4, Pp 227-240 (2023)
Objective Previous analyses of pooled DISCOVER‐1 and DISCOVER‐2 data through Week 24 showed significantly higher rates of dactylitis resolution in patients treated with guselkumab compared with placebo. Here, we investigate associations between d
Externí odkaz:
https://doaj.org/article/b952304b10bc473db051a75aae6f707d
Autor:
Christopher T. Ritchlin, Atul Deodhar, Wolf‐Henning Boehncke, Enrique R. Soriano, Alexa P. Kollmeier, Xie L. Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S. Helliwell
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 3, Pp 149-164 (2023)
Objective To evaluate efficacy and safety of the interleukin‐23p19‐subunit inhibitor, guselkumab, in DISCOVER‐1 patients with active psoriatic arthritis (PsA) by prior use of tumor necrosis factor inhibitor (TNFi). Methods The phase 3, randomiz
Externí odkaz:
https://doaj.org/article/e4930dc2832540c9ac8cbcbd84cd1cd7
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 36, Iss 1, Pp 148-158 (2022)
AbstractSalix triandroides W. P. Fang, an indigenous small willow with high potential for heavy-metal soil remediation and levee protection, has been used for wetland ecological restoration for decades. However, studies on the evolution and genetic b
Externí odkaz:
https://doaj.org/article/1e91e7a963d94ae1843abc61cf3f464b
Autor:
Philip J Mease, Shihong Sheng, Iain B McInnes, Alice B Gottlieb, Proton Rahman, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, May Shawi, Frédéric Lavie
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objective Evaluate relationship between radiographic progression and clinical outcomes in post hoc analyses of patients with psoriatic arthritis (PsA) receiving up to 2 years of guselkumab therapy in the phase 3, placebo-controlled, randomised trial,
Externí odkaz:
https://doaj.org/article/b17bb9edfe8443a8b15ad16f896fb6e3
Autor:
Joseph F Merola, Atul Deodhar, Philip J Mease, Shihong Sheng, Iain B McInnes, Soumya D Chakravarty, Elena Schiopu, Yanli Wang, Wolf-Henning Boehncke, Christopher T Ritchlin, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, May Shawi, Stephen Xu, John Tesser
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/6e550c0266f941509759d9b9b5b88af6
Autor:
Atul Deodhar, Shihong Sheng, Philip S Helliwell, Soumya D Chakravarty, Elizabeth C Hsia, Enrique R Soriano, Chetan S Karyekar, Wolf-Henning Boehncke, Prasheen Agarwal, Alexa P Kollmeier, Federico Zazzetti, Ramanand A Subramanian, Xie L Xu, Qing C Zuraw, Yusang Jiang, Bei Zhou, Yanli Zhuang, May Shawi
Publikováno v:
RMD Open, Vol 7, Iss 1 (2021)
Objective Evaluation of the efficacy and safety of guselkumab, a human monoclonal antibody targeting the interleukin-23p19 subunit, in patients with psoriatic arthritis (PsA) through 1 year.Methods Adults who met ClASsification criteria for Psoriatic
Externí odkaz:
https://doaj.org/article/ae559d22818b49b5b84a51d05b30ba53
Autor:
Brian G Feagan, Bruce E Sands, William J Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao, Shihong Sheng, Jewel Johanns, Julián Panés, Alexander Tkachev, Dilara Kalimullina, Robert Petryka, Marina Osipenko, Nataliia Tsarynna, Leonid Bilianskyi, Dariusz Kleczkowski, Andrii Yurkiv, Marek Woynarowski, Orest Abrahamovych, Olha Ivanishyn, Grazyna Rydzewska, Jaroslaw Kierkus, Elina Petrova, Olga Vasilevskaya, Halyna Afanasieva, Carlos Francesconi, Jaroslaw Leszczyszyn, Elena Bunkova, Dmitry Platonov, Olena Datsenko, Oleksii Gridnyev, Ihor Hospodarsky, Liudmyla Prystupa, Mykola Stanislavchuk, Anatoly Pershko, Oksana Shchukina, Vladimir Simanenkov, Oleksandr Golovchenko, William Holderman, Juan Lasa, Jakob Begun, Maria de Lourdes de Abreu Ferrari, Pedro Lopez, Andrey Obrezan, Shiraz Farooq, Felix Tiongco, Abel Novillo, Emiliano Tron, Finlay Macrae, Rupert Leong, Ligia Yukie Sassaki, Cyrla Zaltman, Roberto Kaiser Junior, Andreas Stallmach, Jochen Klaus, Manuel Martinez, Azalia Ruiz, Rustem Abdulkhakov, Vishvinder Sharma, Louis Korman, James Lord, Bhaktasharan Patel, Timothy Ritter
Publikováno v:
The Lancet Gastroenterology & Hepatology. 8:307-320
Autor:
Christopher T. Ritchlin, Atul Deodhar, Wolf‐Henning Boehncke, Enrique R. Soriano, Alexa P. Kollmeier, Xie L. Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S. Helliwell
Publikováno v:
ACR Open Rheumatology. 5:149-164
Autor:
Proton Rahman, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Iain B. McInnes, May Shawi, Yanli Wang, Shihong Sheng, Alexa P. Kollmeier, Elke Theander, Jenny Yu, Evan Leibowitz, A. Marilise Marrache, Laura C. Coates
Publikováno v:
The Journal of Rheumatology. 50:769-780
ObjectiveAssess pooled safety results through the end of the phase II/III studies of guselkumab (GUS; ≤ 2 years) in tumor necrosis factor inhibitor (TNFi)-naïve and -experienced patients with psoriatic arthritis (PsA).MethodsData were pooled from
Autor:
Rahman, Proton, Boehncke, Wolf-Henning, Mease, Philip J., Gottlieb, Alice B., McInnes, Iain B., Shawi, May, Yanli Wang, Shihong Sheng, Kollmeier, Alexa P., Theander, Elke, Yu, Jenny, Leibowitz, Evan, Marilise Marrache, A., Coates, Laura C.
Publikováno v:
Journal of Rheumatology; Jun2023, Vol. 50 Issue 6, p769-780, 12p